Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Ellume Health
FDA classifies Ellume at-home COVID-19 test recall as ‘most serious’ type
By
Emily Olsen
|
02:14 pm |
November 10, 2021
Ellume began recalling the tests last month for giving false positive results.
